Total Payments
$5,621
2024 Payments
$17.23
Companies
33
Transactions
359
Medicare Patients
1,842
Medicare Billing
$190,611
Payment Breakdown by Category
Food & Beverage$5,545 (98.7%)
Education$75.42 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,545 | 350 | 98.7% |
| Education | $75.42 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $755.37 | 44 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $713.57 | 34 | $0 (2021) |
| Merck Sharp & Dohme LLC | $654.46 | 53 | $0 (2022) |
| PFIZER INC. | $589.25 | 71 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $515.05 | 27 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $325.67 | 13 | $0 (2020) |
| Shire North American Group Inc | $281.12 | 18 | $0 (2019) |
| Aytu BioScience, Inc | $198.00 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $172.22 | 9 | $0 (2020) |
| Amarin Pharma Inc. | $145.92 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.23 | 1 | Ardelyx, Inc. ($17.23) |
| 2023 | $23.66 | 1 | AbbVie Inc. ($23.66) |
| 2022 | $40.73 | 3 | Merck Sharp & Dohme LLC ($40.73) |
| 2021 | $425.50 | 23 | Biohaven Pharmaceuticals, Inc. ($88.33) |
| 2020 | $829.52 | 55 | AbbVie Inc. ($182.27) |
| 2019 | $1,254 | 89 | Merck Sharp & Dohme Corporation ($246.10) |
| 2018 | $1,630 | 85 | Janssen Pharmaceuticals, Inc ($357.95) |
| 2017 | $1,399 | 102 | Janssen Pharmaceuticals, Inc ($261.34) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: PRIMARY CARE | ||||||
| 07/23/2021 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 06/29/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/04/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $56.30 | General |
| Category: PRIMARY CARE | ||||||
| 03/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 03/18/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: DIABETES | ||||||
| 03/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: VACCINE | ||||||
| 02/09/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $17.41 | General |
| 02/08/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/04/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Diabetes | ||||||
| 01/21/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiology | ||||||
| 01/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 406 | 564 | $129,365 | $48,768 |
| 2022 | 4 | 439 | 661 | $142,356 | $56,897 |
| 2021 | 6 | 409 | 534 | $108,424 | $42,819 |
| 2020 | 8 | 588 | 727 | $110,917 | $42,127 |
Total Patients
1,842
Total Services
2,486
Medicare Billing
$190,611
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 337 | $58,370 | $20,283 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 147 | 147 | $49,910 | $19,739 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 64 | $15,450 | $6,001 | 38.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $5,635 | $2,745 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 212 | 420 | $71,400 | $28,112 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 148 | 148 | $51,800 | $20,841 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 82 | $19,024 | $7,813 | 41.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $132.00 | $131.40 | 99.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 195 | 308 | $52,360 | $18,951 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 112 | 112 | $39,200 | $15,910 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 51 | $11,832 | $5,486 | 46.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,577 | $1,361 | 86.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 29 | 33 | $2,700 | $779.62 | 28.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 19 | 19 | $755.00 | $331.86 | 44.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 135 | 191 | $15,280 | $10,295 | 67.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 81 | 81 | $28,350 | $10,019 | 35.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 221 | $37,570 | $9,430 | 25.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 58 | $13,456 | $4,658 | 34.6% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 64 | 66 | $9,863 | $3,957 | 40.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 18 | 18 | $2,574 | $2,119 | 82.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 64 | 66 | $2,706 | $1,185 | 43.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 26 | 26 | $1,118 | $465.68 | 41.7% |
About Dr. Robert Talamo, MD
Dr. Robert Talamo, MD is a Family Medicine healthcare provider based in Collegeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083722946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Talamo, MD has received a total of $5,621 in payments from pharmaceutical and medical device companies, with $17.23 received in 2024. These payments were reported across 359 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,545).
As a Medicare-enrolled provider, Talamo has provided services to 1,842 Medicare beneficiaries, totaling 2,486 services with total Medicare billing of $190,611. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Collegeville, PA
- Active Since 08/29/2006
- Last Updated 02/26/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083722946
Products in Payments
- XARELTO (Drug) $493.24
- CHANTIX (Drug) $335.59
- FARXIGA (Drug) $286.71
- JANUVIA (Drug) $263.45
- JARDIANCE (Drug) $238.96
- INVOKANA (Drug) $208.29
- Natesto (Drug) $198.00
- MYRBETRIQ (Drug) $154.99
- VYVANSE (Drug) $150.81
- Vascepa (Drug) $145.92
- Trintellix (Drug) $137.78
- Creon (Drug) $134.54
- MYDAYIS (Drug) $130.31
- STEGLATRO (Drug) $124.95
- LYRICA (Drug) $123.67
- TRADJENTA (Drug) $111.09
- UBRELVY (Drug) $102.36
- SPIRIVA RESPIMAT (Drug) $96.55
- Androgel (Drug) $93.00
- VRAYLAR (Drug) $91.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Collegeville
Paul Doghramji, Md, MD
Family Medicine — Payments: $595,992
Family Medicine $595,992
Birgit Wiswe, Md, MD
Family Medicine — Payments: $13,357
Family Medicine $13,357
Timothy Fiorillo, D.o, D.O
Family Medicine — Payments: $4,957
Family Medicine $4,957
Burton Ginsberg, D.o, D.O
Family Medicine — Payments: $3,560
Family Medicine $3,560
Marta Motel, Do, DO
Family Medicine — Payments: $1,129
Family Medicine $1,129
Dr. Ching Yeung, Do, DO
Family Medicine — Payments: $1,048
Family Medicine $1,048